NASDAQ: COEP
Coeptis Therapeutics Holdings Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their COEP stock forecasts and price targets.

Forecast return on equity

Is COEP forecast to generate an efficient return?

Company
-9.46%
Industry
80.36%
Market
344.77%
COEP's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is COEP forecast to generate an efficient return on assets?

Company
-6.91%
Industry
23.95%
COEP is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

COEP earnings per share forecast

What is COEP's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.17
Avg 2 year Forecast
-$0.17
Avg 3 year Forecast
-$0.18

COEP revenue forecast

What is COEP's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0-100%
Avg 2 year Forecast
$0.0-100%
COEP's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

COEP revenue growth forecast

How is COEP forecast to perform vs Biotechnology companies and vs the US market?

Company
-100%
Industry
295.38%
Market
58.97%
COEP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
COEP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

COEP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
COEP$15.96N/AN/A
ACET$0.56$8.50+1,417.86%Strong Buy
PRLD$1.35$4.00+197.40%Buy
CSBR$6.06N/AN/A
THAR$2.37N/AN/A

Coeptis Therapeutics Holdings Stock Forecast FAQ

What is COEP's earnings growth forecast for 2025-2027?

(NASDAQ: COEP) Coeptis Therapeutics Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 75.54%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 105.64%.

Coeptis Therapeutics Holdings's earnings in 2025 is -$11,279,683.On average, 3 Wall Street analysts forecast COEP's earnings for 2025 to be -$925,975, with the lowest COEP earnings forecast at -$889,662, and the highest COEP earnings forecast at -$953,210. On average, 3 Wall Street analysts forecast COEP's earnings for 2026 to be -$925,975, with the lowest COEP earnings forecast at -$889,662, and the highest COEP earnings forecast at -$953,210.

In 2027, COEP is forecast to generate -$980,444 in earnings, with the lowest earnings forecast at -$941,996 and the highest earnings forecast at -$1,009,281.

If you're new to stock investing, here's how to buy Coeptis Therapeutics Holdings stock.

What is COEP's revenue growth forecast for 2025-2026?

(NASDAQ: COEP) Coeptis Therapeutics Holdings's forecast annual revenue growth rate of -100% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 295.38%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.97%.

Coeptis Therapeutics Holdings's revenue in 2025 is $500,996.On average, 3 Wall Street analysts forecast COEP's revenue for 2025 to be $0, with the lowest COEP revenue forecast at $0, and the highest COEP revenue forecast at $0.

In 2026, COEP is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is COEP's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: COEP) forecast ROA is -6.91%, which is lower than the forecast US Biotechnology industry average of 23.95%.

What is COEP's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: COEP) Coeptis Therapeutics Holdings's current Earnings Per Share (EPS) is -$4.31. On average, analysts forecast that COEP's EPS will be -$0.17 for 2025, with the lowest EPS forecast at -$0.17, and the highest EPS forecast at -$0.18. On average, analysts forecast that COEP's EPS will be -$0.17 for 2026, with the lowest EPS forecast at -$0.17, and the highest EPS forecast at -$0.18. In 2027, COEP's EPS is forecast to hit -$0.18 (min: -$0.18, max: -$0.19).

What is COEP's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: COEP) forecast ROE is -9.46%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.